Vaccines

In 2022, our team helped respond to the Mpox outbreak in British Columbia, which was centred on populations of 2SGBTQ+ men. We conducted a study to measure the uptake of Mpox vaccine, with a baseline survey conducted in August, five weeks after the launch of the first dose vaccination campaign. We then conducted a follow up survey nine months later to see how many men had both doses of the Mpox vaccine.